CN1456341A - Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof - Google Patents
Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof Download PDFInfo
- Publication number
- CN1456341A CN1456341A CN03131642A CN03131642A CN1456341A CN 1456341 A CN1456341 A CN 1456341A CN 03131642 A CN03131642 A CN 03131642A CN 03131642 A CN03131642 A CN 03131642A CN 1456341 A CN1456341 A CN 1456341A
- Authority
- CN
- China
- Prior art keywords
- heat
- oral liquid
- clearing away
- away lung
- lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 102
- 238000002360 preparation method Methods 0.000 title claims description 31
- 208000009421 viral pneumonia Diseases 0.000 title claims description 28
- 206010035737 Pneumonia viral Diseases 0.000 title claims description 27
- 238000000034 method Methods 0.000 title claims description 12
- 210000004072 lung Anatomy 0.000 title description 34
- 239000003814 drug Substances 0.000 claims abstract description 61
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 19
- 229930006000 Sucrose Natural products 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 10
- 230000001954 sterilising effect Effects 0.000 claims abstract description 7
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 229960004793 sucrose Drugs 0.000 claims abstract description 5
- 239000006228 supernatant Substances 0.000 claims abstract description 5
- 238000009835 boiling Methods 0.000 claims abstract 2
- 210000000582 semen Anatomy 0.000 claims description 53
- 229940079593 drug Drugs 0.000 claims description 34
- 239000005720 sucrose Substances 0.000 claims description 18
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 15
- 241000255791 Bombyx Species 0.000 claims description 11
- 235000012907 honey Nutrition 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 10
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 9
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 claims description 9
- 235000019634 flavors Nutrition 0.000 claims description 9
- 239000004302 potassium sorbate Substances 0.000 claims description 9
- 229940069338 potassium sorbate Drugs 0.000 claims description 9
- 235000010241 potassium sorbate Nutrition 0.000 claims description 9
- 229940013618 stevioside Drugs 0.000 claims description 9
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 9
- 235000019202 steviosides Nutrition 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 7
- 230000006837 decompression Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 230000004087 circulation Effects 0.000 claims description 3
- 238000012869 ethanol precipitation Methods 0.000 claims description 3
- 238000000703 high-speed centrifugation Methods 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 26
- 206010035664 Pneumonia Diseases 0.000 abstract description 8
- 238000002156 mixing Methods 0.000 abstract description 2
- 230000003612 virological effect Effects 0.000 abstract description 2
- 244000018633 Prunus armeniaca Species 0.000 abstract 2
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 2
- 241000218671 Ephedra Species 0.000 abstract 1
- 206010035742 Pneumonitis Diseases 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 238000000151 deposition Methods 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 27
- 206010062717 Increased upper airway secretion Diseases 0.000 description 25
- 208000026435 phlegm Diseases 0.000 description 25
- 102000014150 Interferons Human genes 0.000 description 16
- 108010050904 Interferons Proteins 0.000 description 16
- 229940079322 interferon Drugs 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
- 230000036760 body temperature Effects 0.000 description 15
- 230000017531 blood circulation Effects 0.000 description 14
- 102000000588 Interleukin-2 Human genes 0.000 description 13
- 108010002350 Interleukin-2 Proteins 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 13
- 208000006673 asthma Diseases 0.000 description 13
- 238000011160 research Methods 0.000 description 12
- 208000011580 syndromic disease Diseases 0.000 description 12
- 241000283973 Oryctolagus cuniculus Species 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 9
- 208000037656 Respiratory Sounds Diseases 0.000 description 9
- 229940090044 injection Drugs 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 8
- 239000002158 endotoxin Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 206010037833 rales Diseases 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000003172 expectorant agent Substances 0.000 description 6
- 230000003419 expectorant effect Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000002685 pulmonary effect Effects 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000711404 Avian avulavirus 1 Species 0.000 description 5
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical group CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000029142 excretion Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 229960000329 ribavirin Drugs 0.000 description 4
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000003437 trachea Anatomy 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 241001113283 Respirovirus Species 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 238000002555 auscultation Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical group O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 2
- BOJKULTULYSRAS-OTESTREVSA-N Andrographolide Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/[C@H](O)COC1=O BOJKULTULYSRAS-OTESTREVSA-N 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 240000009138 Curcuma zedoaria Species 0.000 description 2
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- 206010041956 Stasis syndrome Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 206010048245 Yellow skin Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- ASLUCFFROXVMFL-UHFFFAOYSA-N andrographolide Natural products CC1(CO)C(O)CCC2(C)C(CC=C3/C(O)OCC3=O)C(=C)CCC12 ASLUCFFROXVMFL-UHFFFAOYSA-N 0.000 description 2
- 230000001147 anti-toxic effect Effects 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000005634 blind loop syndrome Diseases 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 229940093181 glucose injection Drugs 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000008570 maxingshigan Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000010681 turmeric oil Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000002562 urinalysis Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 235000019509 white turmeric Nutrition 0.000 description 2
- 206010011703 Cyanosis Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000032754 Infant Death Diseases 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039109 Rhonchi Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229940067131 aspirin 100 mg Drugs 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 229940095282 codeine phosphate 15 mg Drugs 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003067 hemagglutinative effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000000534 thyroid cartilage Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940100050 virazole Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031316425A CN1209158C (en) | 2003-06-03 | 2003-06-03 | Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031316425A CN1209158C (en) | 2003-06-03 | 2003-06-03 | Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1456341A true CN1456341A (en) | 2003-11-19 |
CN1209158C CN1209158C (en) | 2005-07-06 |
Family
ID=29411754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031316425A Expired - Lifetime CN1209158C (en) | 2003-06-03 | 2003-06-03 | Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1209158C (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102429972A (en) * | 2010-12-23 | 2012-05-02 | 河南天方药业中药有限公司 | Oral liquid for treating virus bronchopneumonia of children and preparation process thereof |
CN103735638A (en) * | 2013-10-25 | 2014-04-23 | 北京农学院 | Traditional Chinese medicine compound preparation for treating livestock and poultry respiratory tract disease |
-
2003
- 2003-06-03 CN CNB031316425A patent/CN1209158C/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102429972A (en) * | 2010-12-23 | 2012-05-02 | 河南天方药业中药有限公司 | Oral liquid for treating virus bronchopneumonia of children and preparation process thereof |
CN103735638A (en) * | 2013-10-25 | 2014-04-23 | 北京农学院 | Traditional Chinese medicine compound preparation for treating livestock and poultry respiratory tract disease |
Also Published As
Publication number | Publication date |
---|---|
CN1209158C (en) | 2005-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1210047C (en) | Medicine for treating cold and preparation method thereof | |
CN104857435B (en) | A kind of Traditional Chinese medicine compound composition with antitumor activity and its preparation method and application | |
CN1232698A (en) | Health beverage capable of tranquilizing through nourishing the heart | |
CN104857436B (en) | Traditional Chinese medicine compound composition with resisting liver cancer activity and its preparation method and application | |
CN1209158C (en) | Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof | |
CN100337658C (en) | Chinese medicine composition for treating cold anemopyretic syndrome, and its preparing method | |
CN1814188A (en) | Vitaminc lonicera and forsythia capsule and preparing method | |
CN102274428B (en) | Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof | |
CN1085788A (en) | Oral liquid | |
CN1148217C (en) | Chinese medicine for treating chronic bronchitis | |
CN1562115A (en) | Antipyretic Chinese medicine preparation for child made of bupleurum root and cinnamon twig | |
CN102038776A (en) | Oral liquid capable of relieving cough and asthma and preparation method thereof | |
CN1686514A (en) | Chinese medicinal preparation for treating anxietas, depression and its production method | |
CN1931208A (en) | Application of common goldenrod herb in preparing medicine for preventing and treating H5N1 bird flu and influenza | |
CN104825784B (en) | A kind of Chinese medicine composition with anti-gastric cancer activity and its preparation method and application | |
CN103263508A (en) | Traditional Chinese medicine composition for treating swine toxoplasmosis as well as preparation and application thereof | |
CN100515452C (en) | Modern Chinese-medicine oral preparation of Fructus schisandrae | |
CN1240418C (en) | Chinese compound medicine for treating gastrodynia and its prepartion method | |
CN102836315A (en) | Chinese medicinal composition for preventing and conditioning prognosis tumors and preparation method thereof | |
CN1176820A (en) | Red ginseng and hawthorn fruit health-care wine | |
CN103169909B (en) | Traditional Chinese medicine composition and preparation method thereof | |
CN1245204C (en) | Medicine for curing acute pharyngitis and its preparing method | |
CN1586543A (en) | Children health pectoral mixture for treating child wind and heat caused by exopathogen and its preparing method | |
CN104840727B (en) | Chinese medicine composition with anti-cancer of the esophagus activity and its preparation method and application | |
CN1281706A (en) | Chinese medicine composition for curing various cancers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHENGDU KANGHONG TECHNOLOGY INDUSTRIAL (GROUP) CO Free format text: FORMER OWNER: NANJING TRADITIONAL CHINESE MEDICINE UNIV. Effective date: 20050812 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20050812 Address after: 610036 No. 36 Shu West Road, Chengdu, Sichuan, Jinniu District Patentee after: Chengdu Kanghong technology industry (Group) Co.,Ltd. Address before: 210029 No. 282, Hanzhoung Road, Nanjing, Jiangsu Patentee before: Nanjing University of Chinese Medicine |
|
ASS | Succession or assignment of patent right |
Owner name: SIBIAN JISHENGTANG MEDICINE CO.,LTD. Free format text: FORMER OWNER: CHENGDU KANGHONG TECHNOLOGY INDUSTRIAL (GROUP) CO., LTD. Effective date: 20080829 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080829 Address after: Pengzhou, Sichuan Province Road North Patentee after: Sichuan Jishengtang Pharmaceutical Co.,Ltd. Address before: No 36, Shu West Road, Chengdu, Sichuan, Jinniu District Patentee before: Chengdu Kanghong technology industry (Group) Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20050706 |
|
CX01 | Expiry of patent term |